Literature DB >> 9475085

A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity.

C F Inglehearn1, E E Tarttelin, C Plant, R E Peacock, M al-Maghtheh, E Vithana, A C Bird, S S Bhattacharya.   

Abstract

Autosomal dominant retinitis pigmentosa (ADRP) is caused by mutations in two known genes, rhodopsin and peripherin/Rds, and seven loci identified only by linkage analysis. Rhodopsin and peripherin/Rds have been estimated to account for 20-31% and less than 5% of ADRP, respectively. No estimate of frequency has previously been possible for the remaining loci, since these can only be implicated when families are large enough for linkage analysis. We have carried out such analyses on 20 unrelated pedigrees with 11 or more meioses. Frequency estimates based on such a small sample provide only broad approximations, while the above estimations are based on mutation detection in much larger clinic based patient series. However, when markers are informative, linkage analysis cannot fail to detect disease causation at a locus, whereas mutation detection techniques might miss some mutations. Also diagnosing dominant RP from a family history taken in a genetic clinic may not be reliable. It is therefore interesting that 10 (50%) of the families tested have rhodopsin-RP, suggesting that, in large clearly dominant RP pedigrees, rhodopsin may account for a higher proportion of disease than had previously been suspected. Four (20%) map to chromosome 19q, implying that this is the second most common ADRP locus. One maps to chromosome 7p, one to 17p, and one to 17q, while none maps to 1cen, peripherin/Rds, 8q, or 7q. Three give exclusion of all of these loci, showing that while the majority of dominant RP maps to the known loci, a small proportion derives from loci yet to be identified.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475085      PMCID: PMC1051177          DOI: 10.1136/jmg.35.1.1

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa.

Authors:  G J Farrar; P Kenna; S A Jordan; R Kumar-Singh; M M Humphries; E M Sharp; D M Sheils; P Humphries
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

Review 2.  Clinical investigation of retinitis pigmentosa.

Authors:  A C Bird
Journal:  Aust N Z J Ophthalmol       Date:  1988-08

3.  Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa.

Authors:  K Kajiwara; L B Hahn; S Mukai; G H Travis; E L Berson; T P Dryja
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

4.  Linkage mapping of autosomal dominant retinitis pigmentosa (RP1) to the pericentric region of human chromosome 8.

Authors:  S H Blanton; J R Heckenlively; A W Cottingham; J Friedman; L A Sadler; M Wagner; L H Friedman; S P Daiger
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

5.  Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site.

Authors:  T J Keen; C F Inglehearn; D H Lester; R Bashir; M Jay; A C Bird; B Jay; S S Bhattacharya
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

6.  Map refinement of locus RP13 to human chromosome 17p13.3 in a second family with autosomal dominant retinitis pigmentosa.

Authors:  T L Kojis; C Heinzmann; P Flodman; J T Ngo; R S Sparkes; M A Spence; J B Bateman; J R Heckenlively
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

7.  A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa.

Authors:  C F Inglehearn; R Bashir; D H Lester; M Jay; A C Bird; S S Bhattacharya
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

8.  Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis.

Authors:  V C Sheffield; G A Fishman; J S Beck; A E Kimura; E M Stone
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

9.  Rhodopsin mutations in autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; C M Davenport; J C Hennessey; I H Maumenee; S G Jacobson; J R Heckenlively; R Nowakowski; G Fishman; P Gouras; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.

Authors:  T P Dryja; L B Hahn; G S Cowley; T L McGee; E L Berson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more
  13 in total

1.  Predictive DNA testing in ophthalmology: View 2.

Authors:  A R Webster
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Dominant retinitis pigmentosa phenotype associated with a new mutation in the splicing factor PRPF31.

Authors:  S Ghazawy; K Springell; V Gauba; M A McKibbin; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

3.  Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

Authors:  Erin R Burnight; Manav Gupta; Luke A Wiley; Kristin R Anfinson; Audrey Tran; Robinson Triboulet; Jeremy M Hoffmann; Darcey L Klaahsen; Jeaneen L Andorf; Chunhua Jiao; Elliott H Sohn; Malavika K Adur; Jason W Ross; Robert F Mullins; George Q Daley; Thorsten M Schlaeger; Edwin M Stone; Budd A Tucker
Journal:  Mol Ther       Date:  2017-06-12       Impact factor: 11.454

4.  A new dominant retinitis pigmentosa family mapping to the RP18 locus on chromosome 1q11-21.

Authors:  C F Inglehearn; E E Tarttelin; T J Keen; S S Bhattacharya; A T Moore; R Taylor; A C Bird
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

5.  RP11 is the second most common locus for dominant retinitis pigmentosa.

Authors:  E Vithana; M Al-Maghtheh; S S Bhattacharya; C F Inglehearn
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

6.  Rhodopsin gene mutation analysis in Iranian patients with autosomal dominant retinitis pigmentosa.

Authors:  Danial Roshandel; Maryam Rafati; Sara Khorami; Nima Novin Baheran; Setareh Jalali; Razieh Tabatabaie; Safura Rezai; Hamid Ahmadieh; Saeed Reza Ghaffari
Journal:  Int Ophthalmol       Date:  2019-04-10       Impact factor: 2.031

7.  A new locus (RP31) for autosomal dominant retinitis pigmentosa maps to chromosome 9p.

Authors:  Myrto Papaioannou; Christina F Chakarova; De Quincy C Prescott; Naushin Waseem; Thorsten Theis; Irma Lopez; Bhavdip Gill; Robert K Koenekoop; Shomi S Bhattacharya
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

8.  Generation of an inbred miniature pig model of retinitis pigmentosa.

Authors:  Jason W Ross; Juan P Fernandez de Castro; Jianguo Zhao; Melissa Samuel; Eric Walters; Cecilia Rios; Patricia Bray-Ward; Bryan W Jones; Robert E Marc; Wei Wang; Liang Zhou; Jennifer M Noel; Maureen A McCall; Paul J DeMarco; Randall S Prather; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-31       Impact factor: 4.799

9.  Characterization of RP1L1, a highly polymorphic paralog of the retinitis pigmentosa 1 (RP1) gene.

Authors:  Sara J Bowne; Stephen P Daiger; Kimberly A Malone; John R Heckenlively; Avril Kennan; Peter Humphries; Dianna Hughbanks-Wheaton; David G Birch; Qin Liu; Eric A Pierce; Jian Zuo; Qian Huang; Danyel D Donovan; Lori S Sullivan
Journal:  Mol Vis       Date:  2003-04-24       Impact factor: 2.367

10.  A homozygous p.Glu150Lys mutation in the opsin gene of two Pakistani families with autosomal recessive retinitis pigmentosa.

Authors:  Maleeha Azam; Muhammad Imran Khan; Andreas Gal; Alamdar Hussain; Syed Tahir Abbas Shah; Muhammad Shakil Khan; Ahmed Sadeque; Habib Bokhari; Rob W J Collin; Ulrike Orth; Maria M van Genderen; A I den Hollander; Frans P M Cremers; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.